The effects of long-term therapy with proton pump inhibitors on meal stimulated gastrin

Dig Liver Dis. 2014 Feb;46(2):125-30. doi: 10.1016/j.dld.2013.09.021. Epub 2013 Nov 6.

Abstract

Background: Dyspepsia develops in healthy volunteers after withdrawal of proton-pump inhibitors. This phenomenon, attributed to rebound acid hypersecretion, is thought to be mediated by reflex hypergastrinemia.

Aims: To measure fasting and postprandial gastrin in patients on long-term proton-pump inhibitor treatment and correlate gastrin levels with the duration of treatment and other potential predictors.

Methods: In this cross sectional study patients, with erosive esophagitis, on long-term proton-pump inhibitor treatment and healthy controls underwent gastrin measurements at baseline and four times following a meal and Helicobacter pylori status was determined.

Results: A total of 100 patients and 50 controls were studied. Pre- and postprandial gastrin levels were higher in patients (p<0.001). No significant correlation was found between the area under the gastrin-curve and the treatment duration. Female patients had significantly higher gastrin levels than males pre- and postprandial, whereas such differences was not found in the control group. Female gender was the only independent predictor of s-gastrin levels (OR 2.50 compared to males, 95% CI: 1.08-5.76, p=0.032) in the patient group.

Conclusion: Gastrin values were higher in patients compared to controls. There was no correlation between gastrin levels and treatment duration. Female patients had significantly higher gastrin values than males.

Keywords: Dyspepsia; GERD; Gastrin; Proton-pump inhibitors.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Aged
  • Case-Control Studies
  • Chromogranin A
  • Cross-Sectional Studies
  • Dyspepsia / blood
  • Dyspepsia / etiology*
  • Esophagitis, Peptic / complications
  • Esophagitis, Peptic / drug therapy*
  • Female
  • Gastrins / blood*
  • Helicobacter Infections / complications
  • Helicobacter pylori
  • Humans
  • Male
  • Middle Aged
  • Postprandial Period*
  • Proton Pump Inhibitors / adverse effects*
  • Sex Factors
  • Substance Withdrawal Syndrome / etiology*

Substances

  • Chromogranin A
  • Gastrins
  • Proton Pump Inhibitors